AXL is crucial for E1A-enhanced therapeutic efficiency of EGFR tyrosine kinase inhibitors through NFI in breast cancer

Chih Ming Su, Tung Wei Hsu, Shian Ying Sung, Ming Te Huang, Kuan Chou Chen, Chih Yang Huang, Chien Yi Chiang, Yen Hao Su, Hsin An Chen, Po Hsiang Liao

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'AXL is crucial for E1A-enhanced therapeutic efficiency of EGFR tyrosine kinase inhibitors through NFI in breast cancer'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences

Earth & Environmental Sciences